메뉴 건너뛰기




Volumn 118, Issue 9, 2002, Pages 327-331

Antithrombotic treatment in hypertensive patients with chronic atrial fibrillation. CARDIOTENS 99 study

Author keywords

Anticoagulation; Atrial fibrillation; Hypertension

Indexed keywords

FIBRINOLYTIC AGENT; ANTICOAGULANT AGENT;

EID: 0037117287     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(02)72375-0     Document Type: Article
Times cited : (12)

References (28)
  • 10
    • 0025241137 scopus 로고
    • The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
    • The Boston Area Anticoagulation Trial for Atrial fibrillation Investigators
    • (1990) N. Engl. J. Med , vol.323 , pp. 1505-1511
  • 13
    • 0025914693 scopus 로고
    • The Stroke Prevention in Atrial Fibrillation study: Final results
    • The Stroke Prevention in Atrial Fibrillation Investigators
    • (1991) Circulation , vol.84 , pp. 527-539
  • 17
    • 9544248668 scopus 로고    scopus 로고
    • Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in atrial fibrillation III randomised clinical trial
    • Stroke Prevention in Atrial Fibrillation Investigators
    • (1996) Lancet , vol.348 , pp. 633-638
  • 26
    • 0027505093 scopus 로고
    • Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke
    • EAFT (European Atrial Fibrillation Trial) study Group
    • (1993) Lancet , vol.342 , pp. 1255-1262
  • 27
    • 2942696888 scopus 로고
    • Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation
    • Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation II study
    • (1994) Lancet , vol.343 , pp. 687-691


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.